Bormioli Pharma S.P.A, founded in Italy, specializes in providing high-quality glass and plastic packaging solutions primarily for the pharmaceutical, healthcare, and cosmetic industries. The company is committed to innovation and sustainability, offering a diverse range of products including vials, bottles, and containers designed to meet stringent regulatory standards.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| BORMPH 9.50% 2028-05-15 EURBormioli Pharma S.P.A | Italy | 2028-05-15 | 9.502 | 6.84 |
| BORMPH 9.50% 2028-05-15 EURBormioli Pharma S.P.A | Italy | 2028-05-15 | 9.502 | 6.84 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Bormioli Pharma S.P.A began its bond issuance in 2019, with a notable €300 million bond issued to finance its strategic growth initiatives and acquisitions. The company’s bonds have gained attention for their favorable yields compared to industry averages, reflecting investor confidence in Bormioli's robust market position. In early 2023, Bormioli announced a significant refinancing program aimed at optimizing its capital structure, which includes plans for further issuances to support expansion efforts and innovations in product development.